Plasma catecholamines and ischemic heart disease

Clinical Cardiology

Volumn 30, Issue 7, 2007, Pages 326-330

  Slavíková, Jana ^a   Kuncová, Jitka ^a   Topolčan, Ondřej ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Acute myocardial infarction; Chronic ischemic heart disease; Epinephrine; Norepinephrine

Indexed keywords

ACUTE HEART INFARCTION; ADRENALIN BLOOD LEVEL; ADRENALIN RELEASE; ADULT; ARTICLE; BLOOD SAMPLING; FEMALE; HEART ARRHYTHMIA; HEART VENTRICLE WALL; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NORADRENALIN BLOOD LEVEL; NORADRENALIN RELEASE; NORMAL VALUE; TIME;

BIOLOGICAL MARKERS; DISEASE PROGRESSION; EPINEPHRINE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NOREPINEPHRINE; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 34547198802     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.20099     Document Type: Article

References (26)

1. Remme WJ: The sympathetic nervous system and ischaemic heart disease. Eur Heart J 1998;19:F62-F71
2. Bacaner M, Brietenbucher J, LaBree J: Prevention of ventricular fibrillation, acute myocardial infarction (myocardial necrosis), heart failure, and mortality by bretylium: is ischemic heart disease primarily adrenergic casdiovascular disease? Am J Ther 2004;11:366-411
3. Remme WJ, de Leeuw PW, Bootsma M, Look MP, Kruijssen DA: Systemic neurohumoral activation and vasoconstriction during pacing-induced acute myocardial ischemia in patients with stable angina pectoris. Am J Cardiol 1991;68:181-186
4. Remme WJ, Kruijssen DA, Look MP, Bootsma M, de Leeuw PW: Systemic and cardiac activation and severity of myocardial ischemia in humans. J Am Coll Cardiol 1994;23:82-91
5. Schömig A, Fischer S, Kurz T, Richardt G, Schömig E: Nonexocytotic release of endogenous catecholamines in the ischemic and anoxic rat heart: mechanism and metabolic requirements. Circ Res 1987;60:194-205
6. Richardt G, Waas W, Kranzhöfer R, Mayer E, Schömig A: Adenosine inhibits exocytotic release of endogenous noradrenaline in the rat heart: a protective mechanism in early myocardial ischemia. Circ Res 1987;61:117-123
7. Schömig A: Adrenergic mechanisms in myocardial infarction: cardiac and systemic catecholamine release. J Cardiovasc Pharmacol 1988;12:S1-S7
8. Sigursson A, Held P, Swedberg K: Short- and long-term neurohumoral activation following acute myocardial infarction. Am Heart J 1993;126:1068-1076
9. Waldenström AP, Hjalmarson AC, Thornell L: A possible role of noradrenaline in the development of myocardial infarction. Am Heart J 1978;95:43-51
10. Malliani A, Schwartz PJ, Zanchetti A: Neural mechanisms in life-threatening arrhythmias. Am Heart J 1980;100:705-715
11. Strange RC, Rowe MJ, Oliver MF: Lack of relation between plasma total catecholamine concentrations and ventricular arrhythmias after acute myocardial infarction. Br Med J 1978;2: 921-922
12. Hjalmarson AC, Olsson G: Myocardial infarction. Effects of β-blocade. Circulation 1991;84:101-107
13. Pitt B: The role of β-adrenergic blocking agents in preventing sudden cardiac death. Circulation 1992;85:1107-1111
14. Schömig A, Dart AM, Dietz R, Mayer E, K-bler W: Release of endogenous catecholamines in the ischemic myocardium of the rat. Part A: Locally mediated release. Circ Res 1984;55:689-701
15. Freeman R: Assessment of cardiovascular autonomic function. Clin Neurophysiol 2006;117:716-730
16. Johansson M, Rundqvist B, Eisenhofer G, Friberg P: Cardiorenal epinephrine kinetics: evidence for neuronal release in the human heart. Am J Physiol 1997;273:H2178-H2185
17. Slavikova J, Kuncova J, Reischig J, Dvorakova M: Catecholaminergic neurons in the rat intrinsic cardiac nervous system. Neurochem Res 2003;28:593-598
18. Goncalvesova E, Krizanova O, Micutkova L, Mravec B, Ksinantova L, et al.: Phenylethanolamine N-methyltransferase gene expression in transplanted human heart. Transplant Proc 2005;37:1340-1342
19. Kaye DM, Lefkovits J, Cox H, Lambert G, Jennings G, et al.: Regional epinephrine kinetics in human heart failure: evidence for extra-adrenal, nonneural release. Am J Physiol 1995;269:H182-H188
20. Kuchel O: Stress and catecholamines. In In Stress Revisited. 1. Neuroendocrinology of Stress. (Eds. Jasmin G, Cantin M), pp 80-103. Basel: Karger, 1991
21. Esler M, Jennings G, Leonard P, Sacharias N, Burke F, et al. Contribution of individual organs to total noradrenaline release in humans. Acta Physiol Scand 1984;527(S): 11-16
22. Brown MJ, Allison DJ, Jenner DA, Lewis PJ, Dollery CT: Increased sensitivity and accuracy of phaeochromocytoma diagnosis achieved by use of plasma-adrenaline estimations and pentolinium-supression test. Lancet 1981;1:174-177
23. Esler M, Jackman G, Bobik A, Leonard P, Kelleiier D, et al.: Norepinephrine kinetics in essential hypertension. Defective neuronal uptake of norepinephrine in some patients. Hypertension 1981;3:149-156
24. Esler M, Jennings G, Korner P, Blombery P, Sacharias N, et al.: Measurement of total and organ-specific norepinephrine kinetics in humans. Am J Physiol 1984;247:E21-E28
25. Goldstein DS, Brush JE, Eisenhofer G, Stull R, Esler M: In vivo measurement of neuronal uptake of norepinephrine in the human heart. Circulation 1988;78:41-48
26. Webb SW, Adgey AA, Pantridge JF: Autonomic disturbance at onset of acute myocardial infarction. Br Med J 1972;3:89-92